Published in EMBO J on November 01, 1991
Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A (2002) 2.72
Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Blood (2015) 1.63
Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells. Proc Natl Acad Sci U S A (1995) 1.61
High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A (1992) 1.42
Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest (2008) 1.42
High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A (1992) 1.37
Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest (1994) 1.18
Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes. PLoS One (2010) 1.09
Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice. J Clin Invest (2007) 1.05
Regulation of iron absorption in hemoglobinopathies. Curr Mol Med (2008) 0.97
In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J Clin Invest (1999) 0.96
Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. Proc Natl Acad Sci U S A (1998) 0.90
Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. Am J Pathol (1994) 0.87
BP1 is a negative modulator of definitive erythropoiesis. Nucleic Acids Res (2006) 0.85
Endothelin-1 receptor antagonists regulate cell surface-associated protein disulfide isomerase in sickle cell disease. FASEB J (2013) 0.83
Treating hemoglobinopathies using gene-correction approaches: promises and challenges. Hum Genet (2016) 0.81
Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. Br J Pharmacol (2016) 0.79
N-ethylmaleimide activates a Cl(-)-independent component of K(+) flux in mouse erythrocytes. Blood Cells Mol Dis (2013) 0.79
Evidence for a bigenic chromatin subdomain in regulation of the fetal-to-adult hemoglobin switch. Mol Cell Biol (2008) 0.78
A recombinant bisphosphoglycerate mutase variant with acid phosphatase homology degrades 2,3-diphosphoglycerate. Proc Natl Acad Sci U S A (1994) 0.78
Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease. J Clin Invest (1996) 0.77
Animal models of β-hemoglobinopathies: utility and limitations. J Blood Med (2016) 0.75
Cardiorespiratory pathogenesis of sickle cell disease in a mouse model. Sci Rep (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys (1963) 20.43
DETERMINATION OF DENSITY DISTRIBUTION OF RED CELL POPULATION. J Lab Clin Med (1964) 3.67
Molecular analysis of the human beta-globin locus activation region. Proc Natl Acad Sci U S A (1989) 3.17
A mouse model for beta-thalassemia. Cell (1983) 2.70
A transgenic mouse model of sickle cell disorder. Nature (1990) 2.05
Globin chain electrophoresis: a new approach to the determination of the G gamma/A gamma ratio in fetal haemoglobin and to studies of globin synthesis. Br J Haematol (1980) 1.99
Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood (1991) 1.97
Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science (1987) 1.61
Human sickle hemoglobin in transgenic mice. Science (1990) 1.54
Hemoglobin O arab in four negro families and its interaction with hemoglobin S and hemoglobin C. N Engl J Med (1970) 1.35
Separation of human hemoglobins by DEAE-cellulose chromatography using glycine-KCN-NaC1 developers. Hemoglobin (1977) 1.32
Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A (1986) 1.23
Refined crystal structure of deoxyhemoglobin S. II. Molecular interactions in the crystal. J Biol Chem (1985) 1.22
Correction of murine beta-thalassemia by gene transfer into the germ line. Science (1986) 1.13
Hypoxia-induced in vivo sickling of transgenic mouse red cells. J Clin Invest (1991) 1.07
A study of membrane protein defects and alpha hemoglobin chains of red blood cells in human beta thalassemia. J Biol Chem (1989) 1.04
Hematology of a murine beta-thalassemia: a longitudinal study. Ann N Y Acad Sci (1985) 1.03
Introduction and expression of the human Bs-globin gene in transgenic mice. Am J Hum Genet (1988) 0.97
Mouse beta thalassemia, a model for the membrane defects of erythrocytes in the human disease. J Biol Chem (1990) 0.91
Facilitation of Hb S polymerization by the substitution of Glu for Gln at beta 121. J Biol Chem (1988) 0.90
Effect of the beta 73 amino acid on the hydrophobicity, solubility, and the kinetics of polymerization of deoxyhemoglobin S. J Biol Chem (1987) 0.86
Ion content and transport and the regulation of volume in sickle cells. Ann N Y Acad Sci (1989) 0.83
Nucleation-controlled aggregation of deoxyhemoglobin S. Participation of hemoglobin A in the aggregation of deoxyhemoglobin S in concentrated phosphate buffer. J Biol Chem (1980) 0.83
Hb Bruxelles: alpha 2A beta (2)41 or 42(C7 or CD1)Phe deleted. Hemoglobin (1989) 0.81
Functional and NMR studies of Hb Sassari (Asp-126 alpha----His); role of the inter-subunit contacts in the affinity control of human hemoglobin. Biochim Biophys Acta (1990) 0.79
Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res (1999) 4.74
Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer (1998) 2.52
A T-cell specific TCR delta DNA binding protein is a member of the human GATA family. EMBO J (1991) 2.14
Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J Biol Chem (1986) 2.05
Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res (1998) 1.80
Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem (1999) 1.74
Isolation of cDNA clones and complete amino acid sequence of human erythrocyte glycophorin C. J Biol Chem (1986) 1.72
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res (2001) 1.72
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol (1993) 1.57
GATA1 and YY1 are developmental repressors of the human epsilon-globin gene. EMBO J (1995) 1.57
Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol (2005) 1.55
Carbon-flux distribution in the central metabolic pathways of Corynebacterium glutamicum during growth on fructose. Eur J Biochem (1998) 1.50
A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia. Proc Natl Acad Sci U S A (1989) 1.48
TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem (1999) 1.48
Diabetic control in 102 insulin-treated out-patients. Diabetologia (1980) 1.47
High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A (1992) 1.42
High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A (1992) 1.37
Tissue-specific splicing mutation in acute intermittent porphyria. Proc Natl Acad Sci U S A (1989) 1.37
Erythroid-specific activity of the glycophorin B promoter requires GATA-1 mediated displacement of a repressor. EMBO J (1992) 1.36
Regulation of embryonic/fetal globin genes by nuclear hormone receptors: a novel perspective on hemoglobin switching. EMBO J (1999) 1.36
Structural study of circulating thymic factor: a peptide isolated from pig serum. II. Amino acid sequence. J Biol Chem (1977) 1.34
Initiation of transcription of the erythroid promoter of the porphobilinogen deaminase gene is regulated by a cis-acting sequence around the cap site. Nucleic Acids Res (1990) 1.32
Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet (1996) 1.31
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet (2009) 1.28
Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics (1989) 1.26
Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest (1991) 1.24
Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood (1998) 1.24
Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum. J Microbiol Methods (2001) 1.24
Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A (1986) 1.23
Chromatin immunoselection defines a TAL-1 target gene. EMBO J (1998) 1.22
Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clin Chem (1997) 1.19
Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest (1994) 1.18
Molecular cloning and sequencing of the human erythrocyte 2,3-bisphosphoglycerate mutase cDNA: revised amino acid sequence. EMBO J (1986) 1.17
Erythroblasts are a source of angiogenic factors. Blood (2001) 1.17
Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia (2011) 1.16
Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood (1996) 1.16
Microscopic viscosity and rotational diffusion of proteins in a macromolecular environment. Biophys J (1999) 1.14
T-cell expression of the human GATA-3 gene is regulated by a non-lineage-specific silencer. J Biol Chem (1999) 1.13
Beta-chain contact sites in the haemoglobin S polymer. Nature (1980) 1.13
Sickle cell disease of transgenic SAD mice. Blood (1994) 1.12
Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest (1993) 1.11
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut (2003) 1.11
The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood (1999) 1.11
p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J (1997) 1.09
Structure and transcription of the human c-mpl gene (MPL). Genomics (1994) 1.08
Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J Exp Med (1998) 1.08
Cloning and sequencing of mRNAs coding for two adult alpha globin chains of the salamander Pleurodeles waltlii. Gene (1986) 1.07
Abnormal hemoglobins: laboratory methods. Hemoglobin (2001) 1.05
A study of membrane protein defects and alpha hemoglobin chains of red blood cells in human beta thalassemia. J Biol Chem (1989) 1.04
Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood (1993) 1.04
Human erythrocyte band 3 polymorphism (band 3 Memphis): characterization of the structural modification (Lys 56----Glu) by protein chemistry methods. Blood (1991) 1.04
Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol (2000) 1.04
Cation- and peptide-binding properties of human centrin 2. FEBS Lett (2000) 1.04
Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization. J Biol Chem (1986) 1.04
Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur J Clin Invest (1989) 1.03
Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopathology (2003) 1.03
Hb Fontainebleau [alpha 21(B2)Ala----pro], a new silent mutant hemoglobin. Hemoglobin (1989) 1.01
Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid (2001) 1.01
Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes. Blood (1992) 0.99
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol (2001) 0.98
Prenatal detection by real-time quantitative PCR and characterization of a new CFTR deletion, 3600+15kbdel5.3kb (or CFTRdele19). Clin Chem (2000) 0.98
Mouse alpha chains inhibit polymerization of hemoglobin induced by human beta S or beta S Antilles chains. Biochim Biophys Acta (1988) 0.98
Covalent binding of glutathione to hemoglobin. II. Functional consequences and structural changes reflected in NMR spectra. J Biol Chem (1986) 0.97
Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood (1996) 0.97
Determination of the spectrum of beta-thalassemia genes in Spain by use of dot-blot analysis of amplified beta-globin DNA. Am J Hum Genet (1988) 0.97
Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J (1995) 0.96
Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas. Oncogene (1998) 0.95
Structure and expression of the human GATA3 gene. Genomics (1994) 0.95
Chromosomal assignment of the human 2,3-bisphosphoglycerate mutase gene (BPGM) to region 7q34----7q22. Hum Genet (1987) 0.94
Rat uroporphyrinogen decarboxylase cDNA: nucleotide sequence and comparison to human uroporphyrinogen decarboxylase. Nucleic Acids Res (1987) 0.93
Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy. Gut (2003) 0.93
Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA. Biochem Biophys Res Commun (1988) 0.92
htert expression correlates with MYC over-expression in human prostate cancer. Int J Cancer (2000) 0.92
Structural study of hemoglobin Hazebrouck, beta 38(C4)Thr----Pro. A new abnormal hemoglobin with instability and low oxygen affinity. FEBS Lett (1984) 0.92
KU 812: a pluripotent human cell line with spontaneous erythroid terminal maturation. Blood (1989) 0.91
Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines. Blood (1994) 0.91
Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase. Circ Res (2000) 0.90
L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol (1992) 0.90
Self-association of haemoglobin Olympia (alpha 2 beta 2 20 (B2) Val----Met). A human haemoglobin bearing a substitution at the surface of the molecule. J Mol Biol (1986) 0.90
[An acquired S hemoglobin in the adult]. Nouv Presse Med (1974) 0.89
Hemoglobin expression in clones of K562 cell line. Eur J Biochem (1982) 0.89
Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells? Blood (1999) 0.89
Insulin injections enhance cholesterol gallstone incidence by changing the biliary cholesterol saturation index and apo A-I concentration in hamsters fed a lithogenic diet. J Hepatol (2001) 0.89
Globin-chain affinity chromatography on Sepharose-haptoglobin: a new method of study of hemoglobin synthesis in reticulocytes, in bone marrow and in colonies of erythroid precursors. Eur J Biochem (1980) 0.89
The human alpha-globin gene. The protein products of the duplicated genes are identical. Eur J Biochem (1980) 0.89
A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition. J Mol Biol (2001) 0.88
Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy. Blood (1996) 0.88
Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo. Blood (2001) 0.88
Hemoglobin Saint Mandé beta 102 (G4) asn replaced by tyr: a new low oxygen affinity variant. FEBS Lett (1981) 0.88
Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients. Cell Death Differ (2007) 0.88
Hemoglobin J Iran alpha 2 beta 2 77 (EF1) his----Asp in a Russian-Armenian family. Hemoglobin (1986) 0.88
Structure of the 5' flanking region of the gene encoding human glycophorin A and analysis of its multiple transcripts. Gene (1989) 0.88
Echinococcus multilocularis: microsatellite polymorphism in U1 snRNA genes. Exp Parasitol (1996) 0.88